All News
Medical Xpress / Measurable residual disease shows strong potential as an early indicator of survival in patients with AML
Sensitive tests designed to detect very small numbers of remaining leukemia cells after treatment, known as measurable residual disease (MRD), may provide an early and reliable indicator of long-term outcomes for patients ...
Phys.org / NASA selects two instruments for Artemis IV lunar surface science
NASA has selected two science instruments designed for astronauts to deploy on the surface of the moon during the Artemis IV mission to the lunar south polar region. The instruments will improve our knowledge of the lunar ...
Phys.org / Scientists enhance the flavor of carob-based chocolate alternatives with novel methods
With climate change and higher incidences of crop diseases, global cocoa production and supply is being threatened. A research team from the National University of Singapore (NUS), motivated by these reports, set out to enhance ...
Medical Xpress / It's so hard to resist overspending at Christmas—here's how to reinforce your willpower
We often throw caution to the cold, dark wind of December when it comes to spending. The cost-of-living crisis may slip our minds amid the razzle-dazzle of Christmas. We just want a moment to enjoy ourselves, to forget about ...
Medical Xpress / FDA approves Itvisma for spinal muscular atrophy
The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in the survival motor neuron ...
Medical Xpress / AI framework speeds up brain neuron modeling
Cedars-Sinai investigators worked with a multi-institutional team to develop a new artificial intelligence framework that can accurately, quickly and efficiently create virtual models of brain neurons. The achievement could ...
Medical Xpress / Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL
Pirtobrutinib, a non-covalent Bruton tyrosine kinase (BTK) inhibitor, met the primary endpoint for non-inferiority in terms of overall response rate in the first head-to-head comparison with ibrutinib, a covalent BTK inhibitor. ...
Medical Xpress / People can identify faces even when features are heavily blended or altered
Humans have a remarkable ability to recognize faces despite variations in appearance. Regardless of aging, changes in weight or facial hair, or even cosmetic surgery, we can usually—but not always—identify individuals ...
Medical Xpress / Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy
Within a year of initiation, a multidisciplinary project to improve screening and treatment for iron deficiency in pregnancy resulted in a six-fold rise in screening rates for iron deficiency in pregnant patients, a 20-fold ...
Medical Xpress / Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient
A new study shows that giving the chemotherapy drug cyclophosphamide after allogeneic hematopoietic cell transplantation, a curative treatment for common types of blood cancer, can make the procedure safe and effective even ...
Phys.org / Possible ancient artifacts are found in a B.C. thrift shop—and archaeology scholars are on the case
An unusual email arrived in the inbox of a faculty member at the department of archaeology at Simon Fraser University in the spring of 2024.
Medical Xpress / New trial shows early signs that 'off-the-shelf' CAR T-cell therapy could transform treatment of myeloma
Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T-cell therapy, which generates CAR T-cells inside the body, could offer a faster, easier and more ...
